Conditions: Down Syndrome; Alopecia; Atopic Dermatitis/Eczema; Hidradenitis Suppurativa; Vitiligo; Psoriasis
Intervention: Drug: Tofacitinib
Sponsors: University of Colorado, Denver; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
**RECRUITING NOW**
Intervention: Drug: Tofacitinib
Sponsors: University of Colorado, Denver; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
